Ovintiv (NYSE:OVV - Get Free Report) was downgraded by Wall Street Zen from a "strong-buy" rating to a "buy" rating in a research note issued on Saturday, Wall Street Zen reports.
Other equities analysts also recently issued reports about the company. Weiss Ratings upgraded Ovintiv from a "buy (b-)" rating to a "buy (b)" rating in a research report on Friday, October 2nd. UBS Group reiterated a "buy" rating and set a $85.00 price target on shares of Ovintiv in a report on Monday, September 14th. National Bank Financial upped their price target on Ovintiv from $94.00 to $95.00 and gave the company an "outperform" rating in a research report on Wednesday, October 28th. Royal Bank Of Canada lifted their price target on Ovintiv from $85.00 to $90.00 and gave the company an "outperform" rating in a research report on Tuesday, October 13th. Finally, Truist Financial boosted their price objective on shares of Ovintiv from $77.00 to $90.00 and gave the company a "buy" rating in a research report on Thursday. Two analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $74.33.
Get Our Latest Report on OVV
Ovintiv Stock Performance
OVV stock opened at $60.55 on Friday. The firm has a market cap of $16.68 billion, a price-to-earnings ratio of 11.00 and a beta of 0.57. Ovintiv has a one year low of $36.81 and a one year high of $73.61. The firm has a 50-day simple moving average of $64.82 and a two-hundred day simple moving average of $58.02. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.01.
Insider Transactions at Ovintiv
In other Ovintiv news, EVP Rachel Moore sold 7,753 shares of Ovintiv stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $63.32, for a total value of $490,919.96. Following the completion of the transaction, the executive vice president owned 72,530 shares in the company, valued at approximately $4,592,599.60. The trade was a 9.66% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.85% of the stock is owned by company insiders.
Institutional Trading of Ovintiv
Institutional investors have recently modified their holdings of the business. Aberdeen Wealth Management LLC acquired a new position in Ovintiv in the second quarter valued at about $32,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of Ovintiv in the 2nd quarter worth about $32,000. Markowski Investments bought a new stake in Ovintiv in the 2nd quarter valued at $39,000. Eurizon Capital SGR S.p.A. boosted its holdings in shares of Ovintiv by 289.3% in the 3rd quarter. Eurizon Capital SGR S.p.A. now owns 1,016 shares of the company's stock valued at $60,000 after buying an additional 755 shares in the last quarter. Finally, Heritage Family Offices LLP purchased a new stake in Ovintiv in the 3rd quarter valued at about $72,000. 83.81% of the stock is currently owned by hedge funds and other institutional investors.
Ovintiv Company Profile
(
Get Free Report)
Ovintiv Inc is an independent energy company engaged in the exploration, development, production and marketing of oil, condensate, natural gas liquids and natural gas. The company's operations are focused on North America, with production and resource development activities in the United States and Canada.
Ovintiv's U.S. operations include assets in the Permian Basin of Texas and New Mexico and the Uinta Basin of Utah. In Canada, the company's portfolio includes the Montney and Horn River natural gas and liquids-rich plays in British Columbia and Alberta.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ovintiv, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ovintiv wasn't on the list.
While Ovintiv currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.